Stock Market Highlights: SENSEX up marginally at 79,496; NIFTY dips 6.9 points to 24,141
5 min read | Updated on November 11, 2024, 15:44 IST
SUMMARY
Benchmark indices settled in the mix on Monday, with NIFTY50 down 6.9 points and SENSEX up 9.8 points. In the NIFTY50 space, 30 stocks declined. Asian Paints, Britannia and Apollo Hospital were among the top losers.
SENSEX up marginally at 79,496; NIFTY dips 6.9 points to 24,141
Benchmark indices settled in the mix on Monday, with NIFTY50 down 6.9 points and SENSEX up 9.8 points. In the NIFTY50 space, 30 stocks declined. Asian Paints, Britannia and Apollo Hospital were among the top losers.
November 11, 2024, 15:44 PM
Indosolar posts ₹9.48 crore net profit in Q2
Indosolar on Monday reported a net profit of ₹9.48 crore in the September 2024 quarter, on account of higher income.
It posted a loss of ₹3.20 crore in the year-ago period, the company said in an exchange filing.
November 11, 2024, 15:11 PM
Vedanta Group plans to invest USD 500 mn in AvanStrate Inc
Metals and mining giant Vedanta Ltd is planning to invest close to USD 500 million in its display glass unit AvanStrate Inc, the company said on Monday.
Vendanta Group has expressed interest in setting up a display semiconductor manufacturing unit in India.
"Vedanta Limited is planning to invest close to USD 500 million (about Rs 4,300 crore) in its group company, AvanStrate Inc. (ASI), a leading global display glass manufacturer that is now fully managed by Vedanta Limited," it said in a statement.
November 11, 2024, 14:28 PM
Maruti Suzuki strengthens product range; introduces all-new Dzire
Maruti Suzuki India Ltd on Monday introduced the all-new version of its compact sedan Dzire and said the automaker would continue to cater to all customer segments in order to preserve its high market share in the domestic market.
November 11, 2024, 14:07 PM
Alembic Pharmaceuticals gets USFDA nod for generic hypertension treatment capsules
Alembic Pharmaceuticals Ltd on Monday said it has received final approval from the US health regulator for its generic Diltiazem Hydrochloride extended-release capsules indicated for the treatment of hypertension.
November 11, 2024, 13:38 PM